Clinical Scorecard: Counseling Patients About Gene Therapy

At a Glance

Key Highlights

• Gene therapy represents a paradigm shift in the treatment of IRDs.
• Eligibility for gene therapy is primarily determined by genetic testing results.
• Patients may have unrealistic expectations about treatment outcomes.
• Involvement of genetic counselors is crucial for interpreting genetic tests.
• Clinical trials have specific inclusion and exclusion criteria to ensure patient safety.

Guideline-Based Recommendations

Diagnosis

• Confirm eligibility through genetic testing, focusing on biallelic pathogenic variants.

Management

• Provide balanced information about gene therapy and its potential outcomes.

Monitoring & Follow-up

• Assess patient understanding and expectations regarding treatment outcomes.

Risks

• Discuss potential adverse events associated with gene therapy and clinical trial participation.

Patient & Prescribing Data

Individuals diagnosed with inherited retinal diseases, particularly those with specific genetic mutations.

Current gene therapies aim to slow disease progression, with some targeting restoration of vision.

Clinical Best Practices

• Engage patients in discussions about their expectations and desired outcomes.
• Utilize genetic counselors to aid in the interpretation of genetic testing results.
• Ensure patients understand the risks and benefits of participating in clinical trials.

References

• Gene Therapy Overview
• FDA Approval of Luxturna
• Patient Expectations in Gene Therapy